|
FAM111A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.93416999999529E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.362400E-04 |
| Normal-vs-Stage2 |
6.706200E-02 |
| Normal-vs-Stage3 |
9.902200E-01 |
| Normal-vs-Stage4 |
7.842200E-01 |
| Stage1-vs-Stage2 |
5.968800E-01 |
| Stage1-vs-Stage3 |
4.777700E-03 |
| Stage1-vs-Stage4 |
2.514800E-01 |
| Stage2-vs-Stage3 |
7.599900E-02 |
| Stage2-vs-Stage4 |
2.814200E-01 |
| Stage3-vs-Stage4 |
7.512800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.68459999999793E-05 |
| Normal-vs-AfricanAmerican |
9.859400E-03 |
| Normal-vs-Asian |
3.497400E-01 |
| Caucasian-vs-AfricanAmerican |
5.437400E-01 |
| Caucasian-vs-Asian |
9.336000E-01 |
| AfricanAmerican-vs-Asian |
7.664800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67749999999689E-05 |
| Normal-vs-Female |
8.183700E-03 |
| Male-vs-Female |
3.767000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.594400E-02 |
| Normal-vs-Extreme_Weight |
3.762000E-03 |
| Normal-vs-Obese |
1.642850E-03 |
| Normal-vs-Extreme_Obese |
1.976020E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.396600E-01 |
| Normal_Weight-vs-Obese |
2.329200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.858600E-01 |
| Extreme_Weight-vs-Obese |
4.139400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.349800E-01 |
| Obese-vs-Extreme_Obese |
5.730200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.506500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.20519999996716E-06 |
| Normal-vs-Age(61-80Yrs) |
1.124770E-03 |
| Normal-vs-Age(81-100Yrs) |
8.051200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.918200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.955800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.689600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.343970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.838300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.182620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.30629999542487E-08 |
| Normal-VS-Type2 PRCC |
6.880800E-01 |
| Normal-VS-KIRP CIMP |
2.542200E-01 |
| Normal-VS-Unclassified PRCC |
5.482800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.86569999741593E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.388170E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.076000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.464000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.696500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.845600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.025200E-01 |
| Normal-vs-N1 |
6.320200E-02 |
| Normal-vs-N2 |
1.041200E-01 |
| N0-vs-N1 |
4.754200E-01 |
| N0-vs-N2 |
1.978460E-03 |
| N1-vs-N2 |
1.477950E-03 |
|
|
